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Ductal carcinoma in situ (DCIS) of the breast is becoming
one of the most important diseases diagnosed in preventive
medicine screening. The current age-adjusted incidence rate
of DCIS is 32.5 per 100,000 women. For women 50–64
years of age, the incidence is approximately 88 per 100,000.
Currently, for every 4 diagnoses of invasive breast cancer,
there is 1 diagnosis of DCIS. Risk of DCIS is rare in women
younger than 30 years of age and is low in women under 40
years of age, but increases steadily from ages 40–50. The risk
of DCIS increases much more slowly after the age of 50, and
it plateaus after the age of 60.
Assuming constant incidence and survival rates, it is
estimated that more than 1million women will be living with
diagnosed DCIS by 2020, with obvious social and political
health ramifications. The question scientists are facing now,
and the question women are beginning to ask their breast
surgeons, is whether we are overdiagnosing and overtreating
this disease.
Should we be less aggressive and more tolerant toward
this disease? We are aware that DCIS is a spectrum of dif-
ferent diseases and that we may have overdiagnosed and
overtreated to a point, but we have also likely undertreated
others. Despite randomized clinical trials and evidence-
based recommendations, there are important regional and
geographic diﬀerences in clinical management, reflecting
both a cultural bias regarding, and the heterogeneity of, this
disease.
In this current issue, the authors present a detailed
overview of the state of the art of the diagnosis and treatment
of this disease as well as an overview of future tendencies and
research.
M. Badruddoja extensively reviews the most recent
knowledge of epidemiology and risk factors for DCIS.
L. Fortunato et al. and M. Amichetti et al. review all the
randomized clinical trials on DCIS, giving an unbiased inter-
pretation of the data that is helpful in the daily management
of DCIS patients.
K. Lambert et al., in their literature review facilitated
by the Medline, PubMed, Embase, and Cochrane databases,
consider randomized, nonrandomized, prospective, and ret-
rospective studies with the goal of increasing understanding
of the most important predictive factors for local recurrence,
and of better selection of the use of radiation therapy and
tamoxifen.
The still debatable issue of sentinel node biopsy in DCIS
is addressed by D. Boler et al., who present their experiences
and discuss literature evidence.
G. Scripcaru and I.M. Zardawi investigate the occurrence
of each architectural growth pattern in mammary DCIS.
Correlating the architecture with nuclear grade, they postu-
late that the comedo pattern can ultimately occur in all types
of DCIS and therefore should not be regarded as a separate
DCIS type.
D. Coradini et al., in an elegant experiment, investigate
the expression patterns of a selected panel of genes associated
with cell polarity and the apical junction complex. They are
able to confirm that atypical ductal hyperplasia and DCIS
are part of a tumorigenic, multistep process with possible
chemoprevention implications.
E. Bastiaannet et al., analyzing 8421 patients with DCIS,
found no excess mortality irrespective of treatment in
women older than 50 years of age, with the important clinical
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implication that local relapse in these womenmay not impact
prognosis.
K. Van Zee and D. Choi et al. from Memorial Sloan-
Kettering Cancer Center investigate many aspects of the
biology, diagnosis, and treatment of DCIS over a 20-year
period with the final development of a nomogram that
incorporates many factors simultaneously to estimate the
risk of local relapse in DCIS treated with conservation
therapy.
Several recent patterns-of-care studies have identified
substantial variation in surgeon decision making regarding
the optimal management of DCIS [1–5]. In September 2009,
the National Institutes of Health convened a conference
to discuss the diagnosis and management of patients with
DCIS because of the complexity and discrepancy in its
management [6].
The papers presented here represent important contribu-
tions toward a better understanding of this disease and its
treatment, and emphasize the need for a multidisciplinary
approach to DCIS.
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